日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies

PCSK9单克隆抗体治疗对心血管风险极高患者的治疗持续性、降脂效果和3年临床结局的影响

Parhofer, Klaus G; Pittrow, David; Birkenfeld, Andreas L; Fraass, Uwe; Hohenstein, Bernd; Siegert, Carsten; Klotsche, Jens; Steinhagen-Thiessen, Elisabeth; Dexl, Stefan; Schettler, Volker J J; Laufs, Ulrich

First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors

首个真实世界证据表明,在接受SGLT2抑制剂治疗的IgA肾病患者中,sparsentan具有疗效

Schanz, Moritz; Seikrit, Claudia; Hohenstein, Bernd; Zimmermann, Aline; Kraft, Leonie; Schricker, Severin; Berger, Susann; Schwab, Andrea; Oberacker, Tina; Latus, Joerg

SGLT2-Inhibition in Patients With Alport Syndrome

SGLT2抑制剂治疗阿尔波特综合征患者

Boeckhaus, Jan; Gale, Daniel P; Simon, James; Ding, Jie; Zhang, Yanqin; Bergmann, Carsten; Turner, A Neil; Hall, Matthew; Sayer, John A; Srivastava, Shalabh; Kang, Hee Gyung; Cerkauskaite-Kerpauskiene, Agne; Gillion, Valentine; Claes, Kathleen J; Krueger, Bastian; de Fallois, Jonathan; Walden, Ulrike; Choi, Mira; Schueler, Markus; Mueller, Roman-Ulrich; Todorova, Polina; Hohenstein, Bernd; Zeisberg, Michael; Friede, Tim; Knebelmann, Bertrand; Halbritter, Jan; Gross, Oliver

Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

PCSK9抑制剂治疗适用的高心血管风险患者管理的新见解:PERI-DYS研究的基线结果

Laufs, Ulrich; Birkenfeld, Andreas L; Fraass, Uwe; Hohenstein, Bernd; Siegert, Carsten; Klotsche, Jens; Steinhagen-Thiessen, Elisabeth; Pittrow, David; Dexl, Stefan; Salmen, Sunnhild; Schettler, Volker J J; Parhofer, Klaus G

SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality)

SARS-CoV-2 感染慢性肾病且既往接受透析治疗的患者:不同大流行时期的描述及其对疾病进程(死亡率)的影响

Pilgram, Lisa; Eberwein, Lukas; Jensen, Bjoern-Erik O; Jakob, Carolin E M; Koehler, Felix C; Hower, Martin; Kielstein, Jan T; Stecher, Melanie; Hohenstein, Bernd; Prasser, Fabian; Westhoff, Timm; de Miranda, Susana M Nunes; Vehreschild, Maria J G T; Lanznaster, Julia; Dolff, Sebastian

Persistent and inducible neogenesis repopulates progenitor renin lineage cells in the kidney

持续性和诱导性新生作用可使肾脏中的肾素谱系祖细胞重新增殖

Hickmann, Linda; Steglich, Anne; Gerlach, Michael; Al-Mekhlafi, Moath; Sradnick, Jan; Lachmann, Peter; Sequeira-Lopez, Maria Luisa S; Gomez, R Ariel; Hohenstein, Bernd; Hugo, Christian; Todorov, Vladimir T

Lipoprotein(a) in nephrological patients

肾病患者的脂蛋白(a)

Hohenstein, Bernd

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial

在接受脂蛋白分离术的杂合子家族性高胆固醇血症患者中使用阿利西尤单抗:ODYSSEY ESCAPE 试验

Moriarty, Patrick M; Parhofer, Klaus G; Babirak, Stephan P; Cornier, Marc-Andre; Duell, P Barton; Hohenstein, Bernd; Leebmann, Josef; Ramlow, Wolfgang; Schettler, Volker; Simha, Vinaya; Steinhagen-Thiessen, Elisabeth; Thompson, Paul D; Vogt, Anja; von Stritzky, Berndt; Du, Yunling; Manvelian, Garen

Extrarenal Progenitor Cells Do Not Contribute to Renal Endothelial Repair

肾外祖细胞不参与肾内皮修复

Sradnick, Jan; Rong, Song; Luedemann, Anika; Parmentier, Simon P; Bartaun, Christoph; Todorov, Vladimir T; Gueler, Faikah; Hugo, Christian P; Hohenstein, Bernd

Neutrophil Extracellular Trap-Related Extracellular Histones Cause Vascular Necrosis in Severe GN

中性粒细胞胞外陷阱相关胞外组蛋白导致重症肾小球肾炎中的血管坏死。

Kumar, Santhosh V R; Kulkarni, Onkar P; Mulay, Shrikant R; Darisipudi, Murthy N; Romoli, Simone; Thomasova, Dana; Scherbaum, Christina R; Hohenstein, Bernd; Hugo, Christian; Müller, Susanna; Liapis, Helen; Anders, Hans-Joachim